Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
2
×
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
fremanezumab
fulcrum therapeutics
gene therapy
What
strategy
2
×
accessing
allegations
approval
bio
biogen’s
biopharmaceutical
companies
convo
day
despite
drug
earlier
employees
executive
fact
failures
feels
frances
frei
future
greyballing
harassment
hasn’t
leadership
littered
live
medical
nash
new
news
optimistic
plans
price
proud
read
records
remains
rider’s
road
Language
Current search:
strategy
×
startups
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@techcrunch.com
6 years ago
Uber’s SVP of leadership and strategy says she hasn’t seen any toxicity
